EARLY TREATMENT WITH TERLIPRESSIN AND ALBUMIN IS EFFECTIVE FOR TYPE-1 HEPATORENAL SYNDROME ASSOCIATED WITH SEPSIS

被引:0
作者
Rodriguez, E. [1 ,2 ]
Elia, C. [1 ,2 ]
Sola, E. [1 ,2 ]
Barreto, R. [1 ,2 ]
Graupera, I. [1 ,2 ]
Andrealli, A. [3 ]
Pereira, G. H. [1 ,2 ]
Ariza, X. [1 ,2 ]
Poca, M. [4 ]
Sanchez, J. [5 ]
Guevara, M. [1 ,2 ]
Soriano, G. [4 ]
Alessandria, C. [3 ]
Fernandez, J. [1 ,2 ]
Arroyo, V. [1 ,2 ]
Gines, P. [1 ,2 ]
机构
[1] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
[3] Univ Turin, Osped San Giovanni Battista, Turin, Italy
[4] Hosp Santa Creu & Sant Pau, Liver Unit, Barcelona, Spain
[5] Hosp Parc Tauli, Sabadell, Spain
关键词
D O I
10.1016/S0168-8278(14)61098-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P937
引用
收藏
页码:S387 / S387
页数:1
相关论文
共 50 条
[31]   When Should We Stop Treatment With Terlipressin and Albumin for Patients With Hepatorenal Syndrome? [J].
Reiberger, Thomas .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (11) :1710-1711
[32]   Hepatorenal syndrome: Response to terlipressin and albumin and its determinants [J].
Sarwar, Shahid ;
Khan, Anwaar A. .
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2016, 32 (02) :274-278
[33]   Terlipressin plus hydroxyethyl starch infusion:: an effective treatment for hepatorenal syndrome [J].
Saner, FH ;
Frühauf, NR ;
Schäfers, RF ;
Lang, HK ;
Malagó, M ;
Broelsch, CE .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (08) :925-927
[34]   Role of Terlipressin and Albumin Combination versus Albumin Alone in Hepatorenal Syndrome [J].
Zafar, Shamail ;
Haque, Israr ;
Tayyab, Ghias Un ;
Khan, Gulsena ;
Chaudry, Nusrat .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 :S175-S176
[35]   BASELINE CREATININE AND HEMODYNAMIC RESPONSE PREDICTS REVERSAL HEPATORENAL SYNDROME TYPE 1 WITH TERLIPRESSIN AND ALBUMIN THERAPY [J].
Molina, E. ;
Fernandez-Castroagudin, J. ;
Ferreiro, R. ;
Iglesias-Canle, J. ;
Larino, J. ;
Alvarez del Castillo, M. ;
Rodriguez, M. S. ;
Dominguez-Munoz, J. E. .
JOURNAL OF HEPATOLOGY, 2012, 56 :S267-S267
[36]   Impact of Acute-on-Chronic Liver Failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome [J].
Piano, S. ;
Schmidt, H. ;
Ariza, X. ;
Amoros, A. ;
Romano, A. ;
Sola, E. ;
Gerbes, A. ;
Bernardi, M. ;
Alessandria, C. ;
Trebicka, J. ;
Gustot, T. ;
Nevens, F. ;
Arroyo, V. ;
Gines, P. ;
Angeli, P. .
DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) :E54-E54
[37]   Terlipressin is superior to midodrine/octreotide for hepatorenal syndrome type 1 [J].
Kalambokis, Georgios N. ;
Baltayiannis, Gerasimos ;
Christodoulou, Dimitrios ;
Christou, Leonidas .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (12) :1428-1429
[38]   Type 1 Hepatorenal Syndrome Terlipressin improves Renal Function [J].
Franke, Katharina .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (09)
[39]   Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome [J].
Piano, Salvatore ;
Gambino, Carmine ;
Vettore, Elia ;
Calvino, Valeria ;
Tonon, Marta ;
Boccagni, Patrizia ;
Gringeri, Enrico ;
Germani, Giacomo ;
Burra, Patrizia ;
Cillo, Umberto ;
Angeli, Paolo .
HEPATOLOGY, 2021, 73 (05) :1909-1919
[40]   A study on clinical outcomes of combination of terlipressin and albumin in Hepatorenal Syndrome [J].
Krishna, Rakhi ;
Raj, Jina ;
Dev, Drishya ;
Prasad, Sruthy C. ;
Reghu, Remya ;
Sudheer, O., V .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (07) :860-864